Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGYG.L Regulatory News (GYG)

  • There is currently no data for GYG

Pre-Close Period Statement

14 Jul 2006 07:00

Gyrus Group PLC14 July 2006 14th July 2006 Gyrus Group PLC Pre-Close Period Statement Reading, UK - Gyrus Group (GYG.L) a leading supplier of medical devices whichreduce trauma and complications in surgery, today provides a pre-close periodupdate ahead of its interim results announcement on 12th September 2006. The Group's reported revenues for the six months to 30th June 2006 areanticipated to be approximately £107 million representing growth of over 125% onthe previous year (2005: £47.3 million). Proforma organic revenue growth (whichassumes a full period comparative for the ACMI business which was acquired on21st July 2005) is expected to be marginally over 10%. The legacy Gyrusbusinesses grew revenue by approximately 17% over the first half of 2005 (12% ona constant exchange rate basis). Good performances from the Group's proprietaryDivisions in the US and the Partnered Technologies Division were partly offsetby a weaker performance in international markets, where the integration ofinternational distributors during the period caused a shortfall in revenues. The Surgical Division's new PlasmaCision-derived products (G400 generator,Plasma Trissector, Plasma J Hook) were introduced to the general surgery marketin late March and the technology has been well received during this initialevaluation phase. At the end of the period there were approximately 100 G400generators either placed or sold into the surgical market and the divisionachieved revenue in excess of $1 million from the PlasmaCision portfolio. The Urology & Gynaecology Division had a slower first half when compared to astrong 2005 result pre-acquisition, however the adoption of PK SuperPulse intothe legacy ACMI urology accounts has started well with sales in excess of theCompany's forecasts. New product introductions, including the early evaluationof the new digital ureteroscope, show significant potential for the second halfof 2006. The integration programme has continued on track and savings from this, togetherwith revenue orientated towards more profitable US domestic disposables sales,is expected to result in a significant enhancement to operating profitability. Subject to any unforeseen adjustments it is anticipated that underlying "adjusted" earnings per share (excluding amortisation of acquired intangibleassets, integration costs and deferred tax adjustments) for the six months to30th June 2006 will be in line with consensus expectations, which currentlystand at 7.3 pence per share (H1 2005: 5.1 pence). Brian Steer, Executive Chairman of Gyrus said: "The first half of 2006 has been a successful period of change; we have madesignificant inroads into the integration programme and have started tore-orientate the legacy ACMI business towards our disposable devices businessmodel. At the same time we have successfully introduced our important newPlasmaCision technology. In addition, we look forward to a number of potentiallysignificant new product launches in the second half of 2006." Enquiries: Gyrus Group PLCBrian Steer Executive Chairman 01189 219 750Simon Shaw Chief Financial Officer 01189 219 750 Financial DynamicsBen Atwell 0207 269 7242 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Dec 20193:09 pmRNSHolding(s) in Company
9th Dec 20197:00 amRNSHolding(s) in Company
4th Dec 20194:25 pmRNSTR-1: Standard form notification of major holdings
17th Oct 20197:00 amRNSDirector/PDMR's Dealing
16th Oct 20192:30 pmRNSTR-1: Standard form notification of major holdings
16th Oct 20192:24 pmRNSTR-1: Standard form notification of major holdings
16th Oct 20197:00 amRNSPDMR Dealing
15th Oct 20198:59 amRNSTR-1: Standard form notification of major holdings
14th Oct 20192:50 pmRNSHolding(s) in Company
11th Oct 20192:06 pmRNSSecond Price Monitoring Extn
11th Oct 20192:00 pmRNSPrice Monitoring Extension
11th Oct 201911:47 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSNew Build Contract Wins
26th Sep 20197:00 amRNSInterim Results
19th Sep 20197:00 amRNSBoard Change - CFO Appointment
31st Jul 20197:00 amRNSTrading Update and Board Change
10th Jul 20197:46 amRNSHolding(s) in Company
8th Jul 20194:20 pmRNSHolding(s) in Company
23rd May 201912:19 pmRNSResult of AGM
21st May 20197:00 amRNSTrading Update
17th Apr 20197:00 amRNSNotice of AGM
5th Apr 20197:00 amRNSGrant of Options
4th Apr 20197:00 amRNSFinal Results
26th Mar 20197:00 amRNSNew Build Contract Wins
28th Jan 20194:40 pmRNSSecond Price Monitoring Extn
28th Jan 20194:35 pmRNSPrice Monitoring Extension
25th Jan 20197:07 amRNSHolding(s) in Company
23rd Jan 20194:52 pmRNSHolding(s) in Company
22nd Jan 20197:00 amRNSFull Year Trading Update
3rd Jan 201910:25 amRNSHolding(s) in Company
20th Dec 20184:08 pmRNSHolding(s) in Company
16th Nov 20184:01 pmRNSPDMR Dealing
14th Nov 20184:17 pmRNSHolding(s) in Company
12th Nov 20187:00 amRNSDirector/PDMR Shareholding
31st Oct 20184:40 pmRNSSecond Price Monitoring Extn
31st Oct 20184:35 pmRNSPrice Monitoring Extension
31st Oct 20182:05 pmRNSSecond Price Monitoring Extn
31st Oct 20182:00 pmRNSPrice Monitoring Extension
31st Oct 20187:00 amRNSTrading Update
20th Sep 20187:00 amRNSInterim Results
24th Jul 20184:35 pmRNSHolding(s) in Company
18th Jul 20184:10 pmRNSHolding(s) in Company
18th Jul 20183:01 pmRNSHolding(s) in Company
18th Jul 201810:17 amRNSPDMR Director Dealing
17th Jul 20184:40 pmRNSSecond Price Monitoring Extn
17th Jul 20184:35 pmRNSPrice Monitoring Extension
16th Jul 20183:47 pmRNSHolding(s) in Company
13th Jul 20185:02 pmRNSDirectors' Dealings
13th Jul 20183:02 pmRNSHolding(s) in Company
13th Jul 20182:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.